BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 10063575)

  • 1. [The ABBI system as a possibility for evaluating non-palpable lesions].
    Winzer KJ; Filimonow S; Guski H; Bick U; Hamm B; Müller JM
    Zentralbl Chir; 1998; 123 Suppl 5():57-62. PubMed ID: 10063575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Minimal invasive surgery in clinically occult breast carcinoma].
    Winzer KJ; Madeja C; Guski H; Filimonow S; Hamm B; Müller JM
    Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():1215-8. PubMed ID: 9574382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Stereotactic tumor biopsy and tumor excision].
    Winzer KJ; Filimonow S; Guski H; Hamm B; Müller JM
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():374-8. PubMed ID: 9931644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Initial experiences with the Advanced Breast Biopsy Instrumentation (ABBI), a system for stereotactic excision of non-palpable breast lesions].
    Oertli D; Zuber M; Müller D; Marti WR; Köchli OR; Torhorst J; Harder F
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():379-83. PubMed ID: 9931645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Three-dimensional breast biopsy and surgery].
    Winzer KJ; Filimonow S; Frohberg HD; Hamm B; Guski H
    Chirurg; 1999 Apr; 70(4):384-93. PubMed ID: 10354834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The advanced breast biopsy instrumentation (ABBI) experience at a community hospital.
    Sheth D; Wesen CA; Schroder D; Boccaccio JE; Lloyd LR
    Am Surg; 1999 Aug; 65(8):726-9; discussion 729-30. PubMed ID: 10432081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Early experience with the advanced breast biopsy instrumentation system in a multicentre study].
    Kwasny W; Tausch C; Haid A; Stierer M; Konstantiniuk P; Wayand U; Sevelda P
    Gynakol Geburtshilfliche Rundsch; 2002; 42(4):212-6. PubMed ID: 12373025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-operative touch preparation cytology; does it have a role in re-excision lumpectomy?
    Valdes EK; Boolbol SK; Cohen JM; Feldman SM
    Ann Surg Oncol; 2007 Mar; 14(3):1045-50. PubMed ID: 17206481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial experience with the advanced breast biopsy instrumentation system.
    Matthews BD; Williams GB
    Am J Surg; 1999 Feb; 177(2):97-101. PubMed ID: 10204548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete percutaneous excision of infiltrating carcinoma at stereotactic breast biopsy: how can tumor size be assessed?
    Liberman L; Zakowski MF; Avery S; Hudis C; Morris EA; Abramson AF; LaTrenta LR; Glassman JR; Dershaw DD
    AJR Am J Roentgenol; 1999 Nov; 173(5):1315-22. PubMed ID: 10541111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local tumor recurrence following breast-conservation therapy: correlation of histopathologic findings with detection method and mammographic findings.
    Giess CS; Keating DM; Osborne MP; Rosenblatt R
    Radiology; 1999 Sep; 212(3):829-35. PubMed ID: 10478253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occult breast lesion localization plus sentinel node biopsy (SNOLL): experience with 959 patients at the European Institute of Oncology.
    Monti S; Galimberti V; Trifiro G; De Cicco C; Peradze N; Brenelli F; Fernandez-Rodriguez J; Rotmensz N; Latronico A; Berrettini A; Mauri M; Machado L; Luini A; Paganelli G
    Ann Surg Oncol; 2007 Oct; 14(10):2928-31. PubMed ID: 17674108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Percutaneous stereotactic biopsy of non-palpable breast lesions using the Advanced Breast Biopsy Instrumentation (ABBI) system: critical evaluation of indication strategies].
    Wedegärtner U; Otto U; Buitrago-Tellez C; Bremerich J; Oertli D; Torhorst J; Bongartz G
    Rofo; 2001 Mar; 173(3):224-8. PubMed ID: 11293864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The Advanced Breast Biopsy Instrumentation (ABBI), a system for stereotactic excision of mammographically suspect nonpalpable findings in the breast].
    Oertli D; Zuber M; Müller D; Marti WR; Köchli OR; Torhorst J; Harder F
    Schweiz Med Wochenschr; 1998 May; 128(21):811-6. PubMed ID: 9642747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small (< 2.0-cm) breast cancers: mammographic and US findings at US-guided cryoablation--initial experience.
    Roubidoux MA; Sabel MS; Bailey JE; Kleer CG; Klein KA; Helvie MA
    Radiology; 2004 Dec; 233(3):857-67. PubMed ID: 15567802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conservative surgery for multifocal/multicentric breast cancer.
    Nijenhuis MV; Rutgers EJ
    Breast; 2015 Nov; 24 Suppl 2():S96-9. PubMed ID: 26303986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous removal of malignant mammographic lesions at stereotactic vacuum-assisted biopsy.
    Liberman L; Dershaw DD; Rosen PP; Morris EA; Abramson AF; Borgen PI
    Radiology; 1998 Mar; 206(3):711-5. PubMed ID: 9494489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lesion localization and surgical resection for non-palpable breast cancer].
    Tang JH; Xu XM; Zheng KE; Qin JW; Zhao XS; Zhang T
    Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):305-7. PubMed ID: 19615290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of microcalcifications that develop at the lumpectomy site after breast-conserving therapy.
    Vora SA; Wazer DE; Homer MJ
    Radiology; 1997 Jun; 203(3):667-71. PubMed ID: 9169686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does intraductal breast cancer spread in a segmental distribution? An analysis of residual tumour burden following segmental mastectomy using tumour bed biopsies.
    Jenkinson AD; Al-Mufti RA; Mohsen Y; Berry MJ; Wells C; Carpenter R
    Eur J Surg Oncol; 2001 Feb; 27(1):21-5. PubMed ID: 11237487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.